(Q80402725)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Paul Declerck

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Agnes Noel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

7

Peter Carmeliet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Catherine Maillard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Maud Jost

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Roger H Lijnen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Ann Gils

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jean-Michel Foidart

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

6986-6990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286708%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207859

31 December 2019

exact match

0 references

cites work

Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207859

7 January 2021

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207859

7 January 2021

Plasminogen promotes sarcoma growth and suppresses the accumulation of tumor-infiltrating macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207859

7 January 2021

Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207859

7 January 2021

Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207859

7 January 2021

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207859

7 January 2021

Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207859

7 January 2021

Mouse aortic ring assay: A new approach of the molecular genetics of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207859

7 January 2021

Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207859

7 January 2021

Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207859

7 January 2021

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207859

7 January 2021

Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207859

7 January 2021